Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 12/23/16

Preclinical Therapeutic Grants Branch (PTGB)

Introduction

The Grants and Contracts Operations Branch (GCOB) was renamed as the Preclinical Therapeutic Grants Branch (PTGB)

PTGB resides in a unique situation in relation to the extramural grant community and the internal, non-grant drug discovery/development activities of the Developmental Therapeutics Program (DTP). Through management of a large grant and cooperative agreement portfolio, PTGB staff maintains extensive interactions with the external research community and can provide advice to foster the drug discovery mandate of the DTP. Such activities include assisting grantees to access the NCI drug and natural product repositories, inviting scientists to participate in a DTP seminar series, and arranging for compound testing and identification of molecular targets in the 60 cell line screen. Staff provides information to grantees and other investigators regarding availability of NCI resources for extramural scientists for development of their agents to clinical trial.

For more information about DTP preclinical therapeutic grants, please contact Min He via hem3@mail.nih.gov